Suraksha Diagnostic Limited share price
NSE: SURAKSHA · ISIN INE877V01027
Key numbers
- Market cap
- ₹ 1,788 Cr
- Current price
- ₹ 343.30
- 52-week high / low
- ₹ 360 / 224
- Stock P/E
- 50.0
- Book value
- ₹ 47.2
- Dividend yield
- 0.15%
- ROCE
- 16.9%
- ROE
- 14.1%
- Debt to equity
- 0.53
- Sales growth (3 yrs)
- 17.8%
- Profit growth (3 yrs)
- 70.3%
- 1-year return
- 7.2%
About Suraksha Diagnostic Limited
Suraksha Diagnostic Limited provides pathological and radiological services through diagnostic centers in India. It offers home collection services; pathology services, such as microbiology, serology, molecular biology, histopathology, cytopathology, clinical pathology, haematology, clinical biochemistry and immunology, immunohistochemistry, fluorescence in-situ hybridization, cytogenetics, flow cytometry, newborn screening, and NGS. The company also provides microarray, QF-PCR, FISH, karyotyping, and NIPT services; X-Ray, MRI scan, CT scan, USG, DEXA scan, Mammography, OPG radiology services; ECG, echocardiogram, stress test and treadmill test, wireless holter monitoring, and PFT cardiology services; EEG, EMG, and NCV neurology services; and upper GI and lower GI endoscopy, sigmoidoscopy, proctoscopy, colonoscopy, and proctosigmoidoscopy gastroenterology services. In addition, it offers clinic services, including dental, physiotherapy, immunology and rheumatology, ENT, eye, and specialty clinics, as well as fetal care; home doctor visit services; online doctor consultation; and doctor curated lab packages for bone and health, men's and women's health, senior citizens, diabetes…
Quarterly results
Consolidated figures in ₹ crores
| Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Sales | 73 | 79 | 78 | 81 | 88 |
| Operating profit | 23 | 24 | 24 | 25 | 30 |
| Net profit | 9 | 9 | 8 | 6 | 13 |
| EPS (₹) | 1.80 | 1.73 | 1.44 | 1.21 | 2.50 |
Peers in Diagnostics & Research
Data for information only, not investment advice. Prices end of day.